Price $0.60 |
Market Cap
26.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.44
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-25.2K
|
FCF
-0.6
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-58.20%
|
ROI
-
|
|
ROA
-50.30%
|
EPS Growth
16.70%
|
Current Ratio
8.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Statera Biopharma Inc (STAB) | $0.03 | - | - | 4.9M | Strong Buy |
| Champions Oncology Inc (CSBR) | $4.05 | - | - | 59.9M | Strong Buy |
| Psychemedics Corp. (PMD) | $5.51 | - | 5.70% | 28.1M | Strong Buy |
| Alimera Sciences Inc (ALIM) | $2.66 | - | - | 17.3M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.35 | - | - | 7.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
